Richard Rosen, MD
A Phase III randomized clinical trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and/or omega-3 Long Chain Poly Unsaturated Fatty Acids (LCPUFAs) as a treatment for AMD, cataract and moderate vision loss.
Study Results are currently being analyzed. Please visit this webpage next month for the study update.
For more information: